Pharma manufacturer expands with purchase of facility in FranceApril 3, 2020A U.S.-based manufacturer of canine and equine joint health pharmaceuticals has expanded its capabilities with the purchase of a European active pharmaceutical ingredient (API) manufacturing plant.
SPONSORED CONTENTHelping manage the hidden signs of stressOur therapeutic nutrition targets underlying stress in cats with GI or urinary issues — helping provide relief to pets and their humans. + Learn More